WCG
LLY icon

Weaver Consulting Group’s Eli Lilly LLY Stock Holding History

Weaver Consulting Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$842K Buy
728
+177
+32% +$209K 0.16% 122
2026
Q2 		$661K Buy
551
+33
+6% +$33.7K 0.14% 132
2026
Q1 		$476K Sell
518
-8
-2% -$8.11K 0.11% 153
2025
Q4 		$565K Hold
526
– – 0.14% 131
2025
Q3 		$401K Buy
526
+28
+6% +$20.8K 0.1% 155
2025
Q2 		$388K Buy
498
+3
+0.6% +$2.33K 0.11% 151
2025
Q1 		$409K Buy
495
+3
+0.6% +$2.5K 0.12% 139
2024
Q4 		$380K Sell
492
-143
-23% -$118K 0.12% 137
2024
Q3 		$563K Buy
635
+44
+7% +$39.6K 0.18% 101
2024
Q2 		$535K Sell
591
-20
-3% -$16K 0.19% 98
2024
Q1 		$475K Buy
611
+5
+0.8% +$3.56K 0.18% 106
2023
Q4 		$353K Buy
606
+10
+2% +$5.84K 0.14% 127
2023
Q3 		$320K Sell
596
-130
-18% -$67K 0.14% 130
2023
Q2 		$340K Buy
726
+53
+8% +$22.2K 0.15% 121
2023
Q1 		$231K Buy
673
+4
+0.6% +$1.35K 0.11% 157
2022
Q4 		$245K Hold
669
– – 0.12% 148
2022
Q3 		$216K Buy
669
+5
+0.8% +$1.58K 0.12% 152
2022
Q2 		$215K Sell
664
-75
-10% -$22.5K 0.12% 153
2022
Q1 		$212K Hold
739
– – 0.1% 164
2021
Q4 		$204K Buy
+739
New +$187K 0.1% 163
2020
Q4 		– Sell
-640
Closed -$95K – 559
2020
Q3 		$95K Hold
640
– – 0.05% 195
2020
Q2 		$105K Buy
640
+9
+1% +$1.38K 0.06% 183
2020
Q1 		$88K Hold
631
– – 0.06% 176
2019
Q4 		$71K Hold
631
– – 0.04% 199
2019
Q3 		$69K Hold
631
– – 0.04% 199
2019
Q2 		$70K Hold
631
– – 0.04% 189
2019
Q1 		$72K Buy
+631
New +$76.7K 0.02% 399

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Goelzer Investment Management
Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return
Private Capital Advisors
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Weaver Consulting Group's LLY Position: Q3 2026 in Review

Weaver Consulting Group increased its Eli Lilly (LLY) stake by 32% in Q3 2026, buying an estimated $209K and bringing the position to 728 shares worth $842K. The position accounts for 0.16% of the portfolio, ranked #122.

Weaver Consulting Group first reported a position in LLY in Q1 2019 and has held it in 27 quarters since. 976 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Weaver Consulting Group held 728 shares of Eli Lilly worth $842K as of Q3 2026.
  • Weaver Consulting Group bought 177 Eli Lilly shares in Q3 2026, an estimated $209K.
  • Eli Lilly made up 0.16% of Weaver Consulting Group's portfolio in Q3 2026, its #122 holding.
  • Weaver Consulting Group first reported a position in Eli Lilly in Q1 2019 and has held it in 27 quarters since.
  • 976 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Weaver Consulting Group's 13F filing for Q3 2026, filed 7 Oct 2026.